This inventor holds 1 USPTO granted patent. Top assignee: Jiangsu Hansoh Pharmaceutical Group Co., Ltd.. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Haizhou Yu: Innovator in Pharmaceutical Chemistry
Introduction
Haizhou Yu is a prominent inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds. His work focuses on improving the quality and efficiency of pharmaceutical production.
Latest Patents
Haizhou Yu holds a patent for a "Crystal form of dapagliflozin intermediate and preparation method therefor." This patent discloses a specific crystal form of the dapagliflozin intermediate, which is crucial for enhancing the quality of dapagliflozin. The preparation method allows for high purification, achieving a sample purity of 99.3% or more. This advancement is significant for industrial production, as it simplifies the preparation process while ensuring high-quality outcomes.
Career Highlights
Yu is associated with Jiangsu Hansoh Pharmaceutical Group Co., Ltd., where he applies his expertise in pharmaceutical development. His innovative approach has led to advancements in the production of essential medications, contributing to the overall improvement of healthcare solutions.
Collaborations
Haizhou Yu has collaborated with notable colleagues, including Xiang Li and Jun Yu. These partnerships have fostered a collaborative environment that enhances research and development efforts within the pharmaceutical industry.
Conclusion
Haizhou Yu's contributions to pharmaceutical chemistry exemplify the impact of innovation in healthcare. His patented work on dapagliflozin intermediates showcases the importance of quality and efficiency in drug production. Through his career, he continues to influence the field positively.